The in vitro activity of BAY v 3522 was compared with the activities of cephalexin, cefaclor, cefuroxime, cefixime, and amoxicllin-clavulanate. MICs (in ,ug/ml) 
The various antimicrobial and pharmacokinetic properties of the oral cephalosporins have been achieved by modifying the basic cephem nucleus, primarily by substituents at C-3 or C-7 (R. N. Jones, Antimicrob. Newsl. 5:1-7, 1988) . BAY v 3522 is a new oral cephalosporin with a Z-propenyl side chain at the C-3 position and a D-(2-aminobenzothiazol-6-yl) glycyl substituent at C-7. In this study, the in vitro activity of BAY v 3522 was compared with the activities of other oral cephalosporins and amoxicillin-clavulanate against a variety of aerobic and facultatively anaerobic pathogens.
The organisms studied included 630 bacterial strains arbitrarily selected from recent isolates (57% from blood) at 
